Rosewood, Thea J.Nho, KwangsikRisacher, Shannon L.Gao, SujuanShen, LiForoud, TatianaSaykin, Andrew J.Alzheimer’s Disease Neuroimaging Initiative2024-03-222024-03-222023-10-27Rosewood TJ, Nho K, Risacher SL, et al. Genome-Wide Association Analysis across Endophenotypes in Alzheimer's Disease: Main Effects and Disease Stage-Specific Interactions. Genes (Basel). 2023;14(11):2010. Published 2023 Oct 27. doi:10.3390/genes14112010https://hdl.handle.net/1805/39409The underlying genetic susceptibility for Alzheimer's disease (AD) is not yet fully understood. The heterogeneous nature of the disease challenges genetic association studies. Endophenotype approaches can help to address this challenge by more direct interrogation of biological traits related to the disease. AD endophenotypes based on amyloid-β, tau, and neurodegeneration (A/T/N) biomarkers and cognitive performance were selected from the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort (N = 1565). A genome-wide association study (GWAS) of quantitative phenotypes was performed using an SNP main effect and an SNP by Diagnosis interaction (SNP × DX) model to identify disease stage-specific genetic effects. Nine loci were identified as study-wide significant with one or more A/T/N endophenotypes in the main effect model, as well as additional findings significantly associated with cognitive measures. These nine loci include SNPs in or near the genes APOE, SRSF10, HLA-DQB1, XKR3, and KIAA1671. The SNP × DX model identified three study-wide significant genetic loci (BACH2, EP300, and PACRG-AS1) with a neuroprotective effect in later AD stage endophenotypes. An endophenotype approach identified novel genetic associations and provided insight into the molecular mechanisms underlying the genetic associations that may otherwise be missed using conventional case-control study designs.en-USAttribution 4.0 InternationalAPOEFDG-PETGWASAmyloid-PETCerebrospinal fluid biomarkersEndophenotypeGenetic interactionGeneticsMagnetic resonance imagingArticle